Gaithersburg, Maryland–(Newsfile Corp. – March 6, 2026) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle Pharma” or the “Company”), the owner of Molecule.ai, an artificial intelligence (“AI”) driven platform for molecular discovery and early-stage drug development, today announced that it has entered into a securities purchase agreement with investors for …
Read More »
Matribhumi Samachar English